|
Leadership Team |
|
 |
Manolo Bellotto, Ph.D. Chief Strategy Officer and General Manager Dr. Manolo Bellotto serves as Chief Strategy Officer and General Manager of Gain Therapeutics. He joined the Company in 2018 with more than 20 years of experience in international pharmaceutical product, medical and advocacy development, commercialization, and international research collaborations in major and rare/orphan disease indications across various continents. Previously, Dr. Bellotto served as director of strategic projects at Mederis, a service provider for pharmaceutical, medical device and medical food companies providing assessment, prioritization, planning and management of product development, medical and market-shaping activities. He developed his career as the director of business development at Aptitude Health, a global healthcare company focusing on oncology insights for the life sciences industry. Dr. Bellotto has also previously served as global product leader at Vifor Pharma, a global specialty pharmaceutical company. Dr. Bellotto has held various positions, such as head of international product management and head of marketing, at Helsinn Healthcare, DKSH Healthcare, European Society for Medical Oncology (ESMO), and Chemo SA. Dr. Bellotto received a Ph.D. in Molecular Developmental Genetics from the University of Zurich after having studied molecular biology at the Biocentre of the University of Basel and at the Fredrich Miescher Institute for Biomedical Research in Basel.
|
Manolo Bellotto, Ph.D.
Partners |
|
Grants |
 |
 |
 |
 |
|
Patient Associations |
 |
 |
 |
 |
|
Centers of Research, Translational Science & Clinical Excellence |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Interested in working with a dynamic team of research, |